4.4 Article

The clinical spectrum of inherited diseases involved in the synthesis and remodeling of complex lipids. A tentative overview

期刊

JOURNAL OF INHERITED METABOLIC DISEASE
卷 38, 期 1, 页码 19-40

出版社

WILEY
DOI: 10.1007/s10545-014-9776-6

关键词

-

向作者/读者索取更多资源

Over one hundred diseases related to inherited defects of complex lipids synthesis and remodeling are now reported. Most of them were described within the last 5 years. New descriptions and phenotypes are expanding rapidly. While the associated clinical phenotype is currently difficult to outline, with only a few patients identified, it appears that all organs and systems may be affected. The main clinical presentations can be divided into (1) Diseases affecting the central and peripheral nervous system. Complex lipid synthesis disorders produce prominent motor manifestations due to upper and/or lower motoneuron degeneration. Motor signs are often complex, associated with other neurological and extra-neurological signs. Three neurological phenotypes, spastic paraparesis, neurodegeneration with brain iron accumulation and peripheral neuropathies, deserve special attention. Many apparently well clinically defined syndromes are not distinct entities, but rather clusters on a continuous spectrum, like for the PNPLA6-associated diseases, extending from Boucher-Neuhauser syndrome via Gordon Holmes syndrome to spastic ataxia and pure hereditary spastic paraplegia; (2) Muscular/cardiac presentations; (3) Skin symptoms mostly represented by syndromic (neurocutaneous) and non syndromic ichthyosis; (4) Retinal dystrophies with syndromic and non syndromic retinitis pigmentosa, Leber congenital amaurosis, cone rod dystrophy, Stargardt disease; (5) Congenital bone dysplasia and segmental overgrowth disorders with congenital lipomatosis; (6) Liver presentations characterized mainly by transient neonatal cholestatic jaundice and non alcoholic liver steatosis with hypertriglyceridemia; and (7) Renal and immune presentations. Lipidomics and molecular functional studies could help to elucidate the mechanism(s) of dominant versus recessive inheritance observed for the same gene in a growing number of these disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Evaluation of CSF1R-related adult onset leukoencephalopathy with axonal spheroids and pigmented glia diagnostic criteria

Xavier Ayrignac, Clarisse Carra-Dalliere, Pekes Codjia, Kevin Mouzat, Giovanni Castelnovo, Emmanuel Ellie, Frederique Etcharry-Bouyx, Serge Belliard, Cecilia Marelli, Florence Portet, Isabelle Le Ber, Francoise Durand-Dubief, Guillaume Mathey, Bruno Stankoff, Imen Dorboz, Severine Drunat, Odile Boespflug-Tanguy, Nicolas Menjot de Champfleur, Serge Lumbroso, Fanny Mochel, Pierre Labauge

Summary: The diagnostic criteria for ALSP have limited sensitivity and modest specificity overall, suggesting the need for a comprehensive approach including magnetic resonance imaging pattern-based analysis and genetic testing like white matter gene panel or whole exome sequencing in patients suspected of genetic leukoencephalopathy.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Clinical Neurology

Motor neuron pathology in CANVAS due to RFC1 expansions

Vincent Huin, Giulia Coarelli, Clement Guemy, Susana Boluda, Rabab Debs, Fanny Mochel, Tanya Stojkovic, David Grabli, Thierry Maisonobe, Bertrand Gaymard, Timothee Lenglet, Celine Tard, Jean Baptiste Davion, Bernard Sablonniere, Marie Lorraine Monin, Claire Ewenczyk, Karine Viala, Perrine Charles, Isabelle Le Ber, Mary M. Reilly, Henry Houlden, Andrea Cortese, Danielle Seilhean, Alexis Brice, Alexandra Durr

Summary: CANVAS caused by RFC1 biallelic expansions is a major cause of inherited sensory neuronopathy. Detection of RFC1 expansion is challenging and CANVAS can be associated with atypical features. In this study, we clinically and genetically characterized 50 patients and found that most of them carried a biallelic expansion in RFC1. In addition to the core CANVAS phenotype, we observed several atypical features such as chronic cough, oculomotor signs, motor neuron involvement, dysautonomia, and parkinsonism. We also propose new guidelines for the screening of RFC1 expansion.
Article Genetics & Heredity

Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi)

Daphne H. Schoenmakers, Shanice Beerepoot, Sibren van den Berg, Laura Adang, Annette Bley, Jaap-Jan Boelens, Francesca Fumagalli, Wim G. Goettsch, Sabine Gronborg, Samuel Groeschel, Peter M. van Hasselt, Carla E. M. Hollak, Caroline Lindemans, Fanny Mochel, Peter G. M. Mol, Caroline Sevin, Ayelet Zerem, Ludger Schols, Nicole Wolf

Summary: A group of experts reached consensus on a core set of data elements for a European Metachromatic Leukodystrophy (MLD) registry. The registry will facilitate research, treatment comparisons, and regulatory requirements related to MLD.

ORPHANET JOURNAL OF RARE DISEASES (2022)

Article Clinical Neurology

Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expression

Shady Rahayel, Christina Tremblay, Andrew Vo, Ying Qiu Zheng, Stephane Lehericy, Isabelle Arnulf, Marie Vidailhet, Jean Christophe Corvol, Jean Francois Gagnon, Ronald B. Postuma, Jacques Montplaisir, Simon Lewis, Elie Matar, Kaylena Ehgoetz Martens, Per Borghammer, Karoline Knudsen, Allan Hansen, Oury Monchi, Bratislav Misic, Alain Dagher

Summary: The brain atrophy in patients with isolated REM sleep behavior disorder (iRBD) can be explained by the dynamics of alpha-synuclein, and it can be recreated using an agent-based modeling approach. This finding supports the concepts of prion-like spread and regional susceptibility in prodromal synucleinopathies.
Article Endocrinology & Metabolism

Postauthorization safety study of betaine anhydrous

Ulrike Muetze, Florian Gleich, Sven F. Garbade, Celine Plisson, Luis Aldamiz-Echevarria, Francisco Arrieta, Diana Ballhausen, Matthias Zielonka, Danijela Petkovic Ramadza, Matthias R. Baumgartner, Aline Cano, Maria Concepcion Garcia Jimenez, Carlo Dionisi-Vici, Pavel Jesina, Henk J. Blom, Maria Luz Couce, Silvia Meavilla Olivas, Karine Mention, Fanny Mochel, Andrew A. M. Morris, Helen Mundy, Isabelle Redonnet-Vernhet, Saikat Santra, Manuel Schiff, Aude Servais, Isidro Vitoria, Martina Huemer, Viktor Kozich, Stefan Koelker

Summary: This study evaluates the postauthorization safety study (PASS) for betaine anhydrous, conducted as a public-private partnership (PPP) between a network and registry for specific diseases and the marketing authorization holder. The study found that although some individuals exceeded the recommended dose, no new or potential risks were identified. The study also resulted in revised recommendations for betaine anhydrous dosage.

JOURNAL OF INHERITED METABOLIC DISEASE (2022)

Article Endocrinology & Metabolism

Influence of early identification and therapy on long-term outcomes in early-onset MTHFR deficiency

Mathilde Yverneau, Stephanie Leroux, Apolline Imbard, Florian Gleich, Alina Arion, Caroline Moreau, Marie-Cecile Nassogne, Marie Szymanowski, Marine Tardieu, Guy Touati, Maria Bueno, Kimberly A. Chapman, Yin-Hsiu Chien, Martina Huemer, Pavel Jesina, Mirian C. H. Janssen, Stefan Koelker, Viktor Kozich, Christian Lavigne, Allan Meldgaard Lund, Fanny Mochel, Andrew Morris, Monica Ruiz Pons, Gloria Liliana Porras-Hurtado, Jean-Francois Benoist, Lena Damaj, Manuel Schiff

Summary: This study describes the clinical and laboratory parameters of early-onset MTHFR deficiency and identifies predictive factors for severe neurodevelopmental outcomes. The findings suggest that early diagnosis and appropriate treatment have benefits in improving outcomes.

JOURNAL OF INHERITED METABOLIC DISEASE (2022)

Letter Multidisciplinary Sciences

Brazil's mangroves: Natural carbon storage

Denilson da S. Bezerra, Adriano de Lima Santos, Janaina Santos Bezerra, Silvana Amaral, Milton Kampel, Liana O. Anderson, Flavia Rebelo Mochel, Jorge Luiz Silva Nunes, Naila Arraes de Araujo, Larissa Nascimento Barreto, Maria do S. S. Pinheiro, Marcio Jose Celeri, Fabricio B. Silva, Alexsandro Mendonca Viegas, Stella Manes, Taissa C. S. Rodrigues, Josue C. Viegas, Ulisses D. V. Souza, Andre L. S. Santos, Celso H. L. Silva-Junior

SCIENCE (2022)

Letter Gastroenterology & Hepatology

Commentary to Aby et al: serum ammonia use - unnecessary, frequent and costly

Johannes Haberle, James Nurse, Fanny Mochel

FRONTLINE GASTROENTEROLOGY (2022)

Article Biochemistry & Molecular Biology

A neuro-metabolic account of why daylong cognitive work alters the control of economic decisions

Antonius Wiehler, Francesca Branzoli, Isaac Adanyeguh, Fanny Mochel, Mathias Pessiglione

Summary: Behavioral activities that require control over automatic routines typically feel effortful and result in cognitive fatigue. This study suggests that the inflated cost of cognitive control, manifested as cognitive fatigue, may be related to the accumulation of potentially toxic substances. Using magnetic resonance spectroscopy, the researchers found that high-demand cognitive work led to higher glutamate concentration in the lateral prefrontal cortex, making cognitive control harder to mobilize after a strenuous workday.

CURRENT BIOLOGY (2022)

Article Clinical Neurology

Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood

Hannah Stamberger, David Crosiers, Ganna Balagura, Claudia M. Bonardi, Anna Basu, Gaetano Cantalupo, Valentina Chiesa, Jakob Christensen, Bernardo Dalla Bernardina, Colin A. Ellis, Francesca Furia, Fiona Gardiner, Camille Giron, Renzo Guerrini, Karl Martin Klein, Christian Korff, Hana Krijtova, Melanie Leffner, Holger Lerche, Gaetan Lesca, David Lewis-Smith, Carla Marini, Dragan Marjanovic, Laure Mazzola, Sarah McKeown Ruggiero, Fanny Mochel, Francis Ramond, Philipp S. Reif, Aurelie Richard-Mornas, Felix Rosenow, Christian Schropp, Rhys H. Thomas, Aglaia Vignoli, Yvonne Weber, Elizabeth Palmer, Ingo Helbig, Ingrid E. Scheffer, Pasquale Striano, Rikke S. Moller, Elena Gardella, Sarah Weckhuysen

Summary: This study investigates the natural history of STXBP1-DEE in adults and reveals that seizures, movement disorders, and functional dependence are still present in adult patients. Understanding the natural history of STXBP1-DEE is crucial for prognosis and future therapeutic trials.

NEUROLOGY (2022)

Article Genetics & Heredity

Next-Generation Sequencing Identifies Novel PMPCA Variants in Patients with Late-Onset Dominant Optic Atrophy

Majida Charif, Arnaud Chevrollier, Naig Gueguen, Selma Kane, Celine Bris, David Goudenege, Valerie Desquiret-Dumas, Isabelle Meunier, Fanny Mochel, Luc Jeanjean, Fanny Varenne, Vincent Procaccio, Pascal Reynier, Dominique Bonneau, Patrizia Amati-Bonneau, Guy Lenaers

Summary: This study identifies heterozygous PMPCA variants as having a causative role in late-onset primary DOA. Functional assays suggest that these variants may affect the fusion-fission balance in mitochondria, leading to the degeneration of retinal ganglion cells.
Article Cardiac & Cardiovascular Systems

Cardiac Outcomes in Adults With Mitochondrial Diseases

Konstantinos Savvatis, Christoffer Rasmus Vissing, Lori Klouvi, Anca Florian, Mehjabin Rahman, Anthony Behin, Abdallah Fayssoil, Marion Masingue, Tanya Stojkovic, Henri Marc Becane, Nawal Berber, Fanny Mochel, Denis Duboc, Bertrand Fontaine, Bjorg Krett, Caroline Stalens, Julie Lejeune, Robert D. S. Pitceathly, Luis Lopes, Malika Saadi, Thomas Gossios, Vincent Procaccio, Marco Spinazzi, Celine Tard, Pascal De Groote, Claire-Marie Dhaenens, Claire Douillard, Andoni Echaniz-Laguna, Ros Quinlivan, Michael G. Hanna, Ali Yilmaz, John Vissing, Pascal Laforet, Perry Elliott, Karim Wahbi

Summary: This study aimed to develop prediction models for heart failure and arrhythmic MACE in patients with mitochondrial diseases. The results showed that specific genetic variants and cardiac assessments could serve as predictors. These models demonstrated high predictive accuracy.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Correction Clinical Neurology

Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (vol 11, 15, 2019)

Fatemah A. Sakr, Michel J. Grothe, Enrica Cavedo, Irina Jelistratova, Marie-Odile Habert, Martin Dyrba, Gabriel Gonzalez-Escamilla, Hugo Bertin, Maxime Locatelli, Stephane Lehericy, Stefan Teipel, Bruno Dubois, Harald Hampel

ALZHEIMERS RESEARCH & THERAPY (2022)

Review Gastroenterology & Hepatology

Diagnosis and management of hepatic encephalopathy: The French recommendations

Dominique Thabut, Charlotte Bouzbib, Lucy Meunier, Manon Haas, Nicolas Weiss, Alexandre Louvet, Francois Imbert-Bismut, Fanny Mochel, Yann Nadjar, Antoine Santiago, Thierry Thevenot, Veronique Duhalde, Frederic Oberti, Claire Francoz, Audrey Coilly, Marie-Noelle Hilleret, Pascal Lebray, Amelie Liou-Schischmanoff, Louise Barbier, Christophe Duvoux, Georges-Philippe Pageaux, Michael Bismuth, Damien Galanaud, Thomas De Broucker, Jean-Francois Cadranel, Vincent Leroy, Vincent Di Martino, Dominique Larrey, Christophe Camus, Olivier Scatton, Victor De Ledinghen, Ariane Mallat, Marika Rudler, Christophe Bureau

Summary: Hepatic encephalopathy (HE) is a frequent and severe complication of liver disease that often goes undiagnosed due to a lack of understanding and consensus on diagnosis. Non-specific symptoms and comorbidities in cirrhotic patients make differential diagnosis challenging. Guidelines are provided to assist clinicians in diagnosing and treating HE. Liver transplantation may be indicated for HE, but its reversibility post-transplantation and the consequences in patients with other neurological disorders remain controversial.

LIVER INTERNATIONAL (2023)

Article Clinical Neurology

Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial

Wolfgang Koehler, Marc Engelen, Florian Eichler, Robin Lachmann, Ali Fatemi, Jacinda Sampson, Ettore Salsano, Josep Gamez, Maria Judit Molnar, Silvia Pascual, Maria Rovira, Anna Vila, Guillem Pina, Itziar Martin-Ugarte, Adriana Mantilla, Pilar Pizcueta, Laura Rodriguez-Pascau, Estefania Traver, Anna Vilalta, Maria Pascual, Marc Martinell, Uwe Meya, Fanny Mochel

Summary: The effect of leriglitazone on disease progression in adult patients with adrenomyeloneuropathy was evaluated. The study found that leriglitazone did not significantly affect the change in the Six-Minute Walk Test distance, but it was generally well tolerated with adverse event rates in line with the expected safety profile for this drug class. Further investigation is needed to determine if leriglitazone can slow the progression of cerebral adrenoleukodystrophy.

LANCET NEUROLOGY (2023)

暂无数据